Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Chemicals that Induce Vitiligo: Hazard and Treatment
Description
In a presentation at the Vitiligo Symposium, Samal Desai discusses the challenges of treating vitiligo, emphasizing the need for effective depigmentation methods for patients with severe cases. He highlights the importance of exploring depigmentation as an option when traditional treatments fail, especially for patients burdened psychologically by their condition. Desai details the use of monobenzyl ether of hydroquinone, a melanocytotoxic agent, and advises dermatologists on its safe and systematic application. He shares practical tips on prescribing the treatment effectively, such as starting with small areas to test for reactions and managing patient expectations about potential side effects, including hair color changes. Additionally, he addresses the issue of chemical leukoderma caused by common products like certain hair dyes and amiquimod, encouraging patients to avoid harmful substances. The presentation concludes with support for research and community groups, emphasizing their role in improving patients' quality of life and providing resources for those affected by vitiligo.
View moreConclusions
- Depigmentation can be a viable treatment option for patients with recalcitrant widespread vitiligo when repigmentation therapies fail.
- Monobenzyl ether of hydroquinone is the most commonly used and effective agent for inducing depigmentation in vitiligo patients.
- Patients should be counseled about the irreversible effects of monobenzyl ether of hydroquinone and the importance of careful application to avoid skin irritation.
- Chemical virtiligo can result from various agents, including monobenzyl ether of hydroquinone, imiquimod, and rhododendrol, which disrupt melanocyte function.
- Counseling patients on the potential risks of topical treatments and the importance of long-term sun protection is crucial.
- Newer depigmentation treatments and methods, such as cryotherapy and laser therapy, can complement traditional methods and provide effective results.
- Caution must be taken to assess and monitor patient's psychological well-being when considering depigmentation options.
- van Geel N, Depaepe L, Speeckaert R. Laser (755 nm) and cryotherapy as depigmentation treatments for vitiligo: a comparative study. J Eur Acad Dermatol Venereol. 2015 Jun; 29(6): 1121-1127.
- Harris JE. Chemical-Induced Vitiligo. Dermatol Clin. 2017;35(2):219-227.
- Yoshikawa M, et al. J Dermatol. doi:10.1111/1346-8138.13694
- Yoshikawa M, et al. Pigment Cell & Melanoma Research. Volume 27, Issue 5, pages 754-763, 26 JUN 2014 DOI: 10.1111/pcmr.12269.
- Li W, Xin H, Ge L, Song H, Cao W. Induction of vitiligo after imiquimod treatment of condylomata acuminata. BMC Infectious Diseases. 2014;14:329. doi:10.1186/1471-2334-14-329.
- Majid I et al. J Cutan Aesthet Surg 2013;6:93-6.